Stock info ONWARD | Filter Basic-Info
Stock: ONWARD (Amsterdam small)
| Last Price | 4.98 | Max Price | 6.58 |
| Min Price | 2.08 | 1 Year return | -19.94 |
| Avg. Target | 13.05 | Expected Return | 162.05 % |
| Sector | Health Care | Subsector | Health Care Eq. & Services |
| Sell | 0 | Rating |
|
| Hold | 0 | Concensus |
|
| Buy | 2 |
Loading...
Sector Review ONWARD
Loading...
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 0 | 2,019,627 | 0.00 % |
| 2020 | 0 | 2,170,562 | 0.00 % |
| 2021 | 0 | 2,404,921 | 0.00 % |
| 2022 | 0 | 2,645,840 | 0.00 % |
| 2023 | 0 | 0 | 0.00 % |
Advice ONWARD
| Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
|---|---|---|---|---|---|
| October 29, 2024 | KBC Securities | ONWARD | Buy | 9.10 | 45.27 % |
| April 08, 2024 | Stifel | ONWARD | Buy | 12.00 | 58.50 % |
| March 11, 2024 | DeGroof Petercam | ONWARD | Buy | 14.10 | 64.68 % |
| September 03, 2024 | KBC Securities | ONWARD | Buy | 9.30 | 46.45 % |
| March 22, 2024 | KBC Securities | ONWARD | Buy | 9.30 | 46.45 % |
| February 09, 2024 | KBC Securities | ONWARD | Buy | 10.00 | 50.20 % |
| March 28, 2023 | DeGroof Petercam | ONWARD | Buy | 14.10 | 66.60 % |
| November 08, 2022 | DeGroof Petercam | ONWARD | Buy | 14.10 | 77.52 % |
| September 13, 2022 | Kepler Capital Markets | ONWARD | Buy | 14.00 | 69.86 % |
| September 13, 2022 | DeGroof Petercam | ONWARD | Buy | 14.50 | 70.90 % |
| April 26, 2022 | DeGroof Petercam | ONWARD | Buy | 14.50 | 66.62 % |
| March 23, 2022 | DeGroof Petercam | ONWARD | Buy | 14.90 | 70.47 % |
News ONWARD
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
ONWARD Medical N.V. ( Euronext : ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announced that KBC Securities, part of the KBC Group -- a leading...
ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)
Clinical experience with investigational ARC-EX® Therapy showcased on the main stage and in clinical abstracts during the 2024 NANS Annual Meeting
EINDHOVEN, the Netherlands — January 25, 2024 — ONWARD Medical N.V. ( Euronext : ONWD), the medical technology company...
ONWARD® TO PARTICIPATE IN BASEL HEALTHTECH CONFERENCE 2024
CEO Dave Marver will discuss the Company’s leadership in health technology, including spinal cord stimulation with brain-computer interfaces
EINDHOVEN, the Netherlands — January 23, 2024 — ONWARD Medical N.V. ( Euronext : ONWD), the medical technology company...
Bryan Garnier Initiates Coverage of ONWARD with a Buy Rating and Target Price of EUR 17.00
ONWARD Medical N.V. ( Euronext : ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces Bryan, Garnier & Co, a leading investment bank focused on growth...
Annual reports ONWARD
No Records Found
Profile ONWARD
No Records Found
Results ONWARD
| Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Revenue |
0
|
0
|
0
|
0
|
0
|
|
| Costs |
0
|
0
|
0
|
10
|
13
|
20
|
| Profit |
0
|
0
|
0
|
-10
|
-13
|
-20
|
| Margin of profit |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| ROI |
0.0
|
0.0
|
0.0
|
96.49
|
90.35
|
62.34
|
Balance ONWARD
| Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Equity |
0
|
0
|
0
|
-10
|
-15
|
-32
|
| Debt |
0
|
0
|
0
|
20
|
38
|
46
|
| Total assets |
0
|
0
|
0
|
10
|
23
|
14
|
| Solvency |
0.0
|
0.0
|
0.0
|
-107.43
|
-63.90
|
-226.22
|
| Cash |
0
|
0
|
0
|
9
|
15
|
6
|
| Cashflow |
0
|
0
|
0
|
-7
|
-10
|
-13
|
| Employees |
0
|
0
|
0
|
0
|
0
|
|
| Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow / Debt |
0.0
|
0.0
|
0.0
|
-0.36
|
-0.26
|
-0.28
|
Details ONWARD
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
0.0
|
0.0
|
0.0
|
0.0
|
4.98
|
| Eps |
0.0
|
0.0
|
-0.33
|
-0.45
|
-0.67
|
| Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
-7.43
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
0.0
|
0.0
|
-0.34
|
-0.50
|
-1.08
|
| Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
-0.22
|
| Cashflow per stock |
0.0
|
0.0
|
-0.24
|
-0.33
|
-0.43
|
| Stocks |
0
|
0
|
30
|
30
|
30
|
| Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
148.41
|
Dividend ONWARD
Price info ONWARD
|
Date
|
Price
|
|---|---|
|
13 Nov 2024
|
4.98
|
|
08 Nov 2024
|
5.02
|
|
05 Nov 2024
|
4.96
|
|
31 Oct 2024
|
4.98
|
|
29 Oct 2024
|
4.89
|
|
23 Oct 2024
|
5.72
|
|
19 Oct 2024
|
5.94
|
|
16 Oct 2024
|
5.90
|
|
14 Oct 2024
|
5.40
|
|
05 Oct 2024
|
5.20
|
|
02 Oct 2024
|
5.20
|
|
27 Sep 2024
|
5.12
|
|
20 Sep 2024
|
4.90
|
|
17 Sep 2024
|
4.77
|
|
13 Sep 2024
|
4.71
|
|
28 Aug 2024
|
4.73
|
|
26 Aug 2024
|
4.70
|
|
23 Aug 2024
|
4.81
|
|
11 Aug 2024
|
4.90
|
|
07 Aug 2024
|
5.06
|
|
05 Aug 2024
|
4.70
|
|
01 Aug 2024
|
4.98
|
|
30 Jul 2024
|
5.06
|
|
26 Jul 2024
|
5.04
|
|
23 Jul 2024
|
5.10
|
|
16 Jul 2024
|
5.30
|
|
10 Jul 2024
|
5.22
|
|
09 Jul 2024
|
4.88
|
|
04 Jul 2024
|
5.00
|
|
02 Jul 2024
|
4.71
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 